Singapore developer of Alzheimer’s drug plans US IPO
SINGAPORE: A Singaporean company focused on developing treatments for Alzheimer’s disease has invited banks to… read more
Alzheimer’s risk genes now linked to brain atrophy
TORONTO: Two genetic variants that were previously linked to Alzheimer’s have now been tied to… read more
Stem cell research showing promise in dementia treatment
WELLINGTON: Dementia is defined as a loss of cognitive or intellectual functioning. Most people are… read more
Changes linked to Alzheimer’s may start by age 45
ST LOUIS: Changes in key biomarkers of Alzheimer’s disease during midlife may help identify those… read more
